{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:29:01Z","timestamp":1772760541630,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.medcli.2024.09.009","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T18:00:38Z","timestamp":1731693638000},"page":"168-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma calprotectin as a biomarker of inflammatory activity in ulcerative colitis"],"prefix":"10.1016","volume":"164","author":[{"given":"Maria Jos\u00e9","family":"Temido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Peixinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros\u00e1rio","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Margarida","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Portela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.09.009_bib0135","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2024.09.009_bib0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD. Part 1. Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.medcli.2024.09.009_bib0145","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0150","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.3748\/wjg.v21.i40.11246","article-title":"Disease monitoring in inflammatory bowel disease","volume":"21","author":"Chang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0155","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031206","article-title":"Diagnostic accuracy of fecal calprotectin for predicting relapse in inflammatory bowel disease: a meta-analysis","volume":"12","author":"Shi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2024.09.009_bib0160","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051408","article-title":"The utility of faecal calprotectin, lactoferrin and other faecal biomarkers in discriminating endoscopic activity in Crohn's disease: a systematic review and meta-analysis","volume":"11","author":"Bohra","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.medcli.2024.09.009_bib0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cca.2020.08.025","article-title":"Calprotectin in inflammatory bowel disease","volume":"510","author":"Khaki-khatibi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.medcli.2024.09.009_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/mp.50.3.113","article-title":"Functional and clinical aspects of the myelomonocyte protein calprotectin","volume":"50","author":"Johne","year":"1997","journal-title":"Mol Pathol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.1001025","article-title":"From bench to bedside: calprotectin (S100A8\/S100A9) as a biomarker in rheumatoid arthritis","volume":"13","author":"Inciarte-Mundo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jbspin.2019.01.003","article-title":"Systemic calprotectin and chronic inflammatory rheumatic diseases","volume":"86","author":"Romand","year":"2019","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.medcli.2024.09.009_bib0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00325481.2017.1319729","article-title":"Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"129","author":"Bae","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.medcli.2024.09.009_bib0190","first-page":"183","article-title":"The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study","volume":"12","author":"Kopi","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.medcli.2024.09.009_bib0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2739\/kurumemedj.MS664009","article-title":"Evaluation of serum calprotectin levels in patients with inflammatory bowel disease","volume":"66","author":"Mori","year":"2019","journal-title":"Kurume Med J"},{"key":"10.1016\/j.medcli.2024.09.009_bib0200","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/j.crohns.2013.06.008","article-title":"Serum calprotectin as a biomarker for Crohn's disease","volume":"7","author":"Meuwis","year":"2013","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.medcli.2024.09.009_bib0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MPG.0000000000002244","article-title":"Serum calprotectin in adolescents with inflammatory bowel disease \u2013 a pilot investigation","volume":"68","author":"Carlsen","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.medcli.2024.09.009_bib0210","first-page":"744","article-title":"The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease","volume":"111","author":"Ferrer","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.medcli.2024.09.009_bib0215","first-page":"107","article-title":"Detection of calprotectin in inflammatory bowel disease: fecal and serum levels and immunohistochemical localization","volume":"41","author":"Fukunaga","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.medcli.2024.09.009_bib0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/00365513.2017.1419371","article-title":"Calprotectin (S100A8\/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis","volume":"78","author":"Nordal","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.medcli.2024.09.009_bib0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/00365519009104950","article-title":"Plasma levels of the calcium-binding LI leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls","volume":"50","author":"Dale","year":"1990","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.medcli.2024.09.009_bib0230","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1080\/00365521.2019.1665097","article-title":"Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative colitis","volume":"54","author":"Malham","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD. Part 2. IBD scores and general principles and technical aspects","volume":"13","author":"Sturm","year":"2019","journal-title":"J Crohn's Colitis"},{"issue":"Suppl. A","key":"10.1016\/j.medcli.2024.09.009_bib0240","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0245","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-ASA for mildely to moderately active ulcerative colitis","volume":"317","author":"Schroeder","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.09.009_bib0250","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ecco-jcc\/jjaa110","article-title":"ECCO position paper: harmonization of the approach to ulcerative colitis histopathology","volume":"14","author":"Magro","year":"2020","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.medcli.2024.09.009_bib0255","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/ajg.2016.342","article-title":"Serum calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases","volume":"111","author":"Kalla","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.medcli.2024.09.009_bib0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10408363.2019.1619159","article-title":"Clinical value of fecal calprotectin","volume":"56","author":"Ricciuto","year":"2019","journal-title":"Crit Rev Clin Lab Sci"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324005979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324005979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T14:13:40Z","timestamp":1739369620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324005979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0025775324005979"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.09.009","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma calprotectin as a biomarker of inflammatory activity in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}